4//SEC Filing
Treacy Paul 4
Accession 0001765581-19-000086
CIK 0001232524other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 5:33 PM ET
Size
6.3 KB
Accession
0001765581-19-000086
Insider Transaction Report
Form 4
Treacy Paul
SVP, Technical Operations
Transactions
- Sale
Ordinary Shares
2019-08-12$137.40/sh−4,371$600,589→ 16,418 total
Holdings
- 106(indirect: By Trust)
Ordinary Shares
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.4015 to $137.4322, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F2]Includes 140 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2019.
- [F3]Represents ordinary shares purchased by Irish Pensions Trust Limited, as trustee for and on behalf of the Reporting Person, as sole beneficiary, pursuant to an Irish Revenue approved profit share scheme on March 15, 2019 in a transaction exempt under Rule 16b-3(c).
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001615763
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 5:33 PM ET
- Size
- 6.3 KB